Community/Retail

Two heads-or 3 in this case-are better than 1.

Jason Turner, PharmD, owner of Moundsville Pharmacy, talks about how medication synchronization improves patient care and brings the pharmacy more business.

R. Jeffrey Hedges, president and CEO of RJ Hedges and Associates, talks about why Medicare Part B, C, and D standards are so important to a pharmacy's business.

Jason Turner, PharmD, owner of Moundsville Pharmacy, talks about factors pharmacists should consider when introducing medication synchronization programs in their pharmacies.

The 2015 American College of Cardiology Annual Scientific Session and Expo featured the latest discoveries in cardiovascular research.

A 20 mg dose of vilazodone HCl (Viibryd) is now available in pharmacies to treat adult patients with major depressive disorder.

Following accusations of conspiracy, a Mississippi pharmacist will pay the federal government $2 million as part of a plea deal.

The computer will replace most of what the health care team does.

The letter was written in response to an opinion column published on March 11, 2015, titled "The Legal Drug Epidemic."

When you put a face on the impact of high-cost specialty drugs, it is hard to ignore the expenses.

The National Association of Chain Drug Stores announces the expansion and acquisition of a certificate program designed to provide training for pharmacists to administer point-of-care testing and other health assessments in pharmacies.

Hospitals with lower rates of 30-day unplanned readmissions tend to have better Facebook ratings than those with higher readmission rates.

The growth in digital health has reached the point where Apple sees a viable way of contributing to medical research through data collected from mobile apps and smartphones.

Valeant Pharmaceuticals International and Salix Pharmaceuticals have entered into an amendment to their Agreement and Plan of Merger, dated February 20, 2015.

IMBRUVICA is jointly developed and commercialized by Janssen Biotech, Inc, and Pharmacyclics, Inc.

Orexo has recently announced that the 8.6-mg/2.1-mg dosage strength of its partial opioid agonist, buprenorphine and naloxone (Zubsolv), is now available in the United States.

More than 90% of HIV transmissions originate from undiagnosed and untreated individuals. On the other hand, those retained in medical care who have achieved viral suppression are 94% less likely to transmit HIV.

From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.

A pharmacist has been lauded by a judge for her efforts to help a domestic violence victim.

The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital.

Some researchers have proposed that vitamin E and selenium supplements may inhibit cataract formation.

Do drug take-back programs in pharmacies do more harm than good?

About 17% of college students misuse stimulant medications prescribed for attention deficit hyperactivity disorder (ADHD), according to a new study published in the Clinical Child and Family Psychology Review.

The National Institutes of Health today admitted an American healthcare worker who tested positive for Ebola virus while volunteering at an Ebola treatment unit in Sierra Leone.

Without allocating more funds toward human papillomavirus vaccinations, there may be better public health results if funds were devoted to vaccinating boys as well as girls.

What shapes an individual's thoughts on his or her health?

Following settlement of the sale, GSK will hold 28.2 million ordinary shares in Aspen, representing approximately 6.2% of the issued share capital.

Loved ones, friends, and health care providers of individuals whom they believe to be at risk of suicide will soon have access to new tools developed by Facebook and SAMHSA that will enable them to better help those in need.

The National Association of Boards of Pharmacy in conjunction with various other stakeholder organizations has recently released a consensus document titled "Stakeholders' Challenges and Red Flag Warning Signs Related to Prescribing and Dispensing Controlled Substances."

Baxter International Inc. announced positive results from its Phase III clinical trial evaluating the safety and efficacy of BAX 817, an investigational recombinant factor VIIa treatment for people with hemophilia A or B who develop inhibitors.